Ingredient

Dapagliflozin Anhydrous Lactose Mixture

Dapagliflozin anhydrous lactose mixture is a blood glucose-lowering ingredient for the treatment of type 2 diabetes.

All medicines
63
Single ingredient
35
Combination
28
Prescription medication
63

MFDS ingredient code M268403

What does it do?

Dapagliflozin anhydrous lactose mixture is a diabetes treatment that belongs to the SGLT2 inhibitor class, used to help control blood glucose levels. This ingredient works by blocking the reabsorption of glucose in the kidneys, thereby lowering blood glucose.

Dapagliflozin inhibits the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, increasing the excretion of glucose in urine. As a result, the concentration of glucose in the blood decreases, leading to improved blood glucose control.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Unlike other glucose-lowering agents, dapagliflozin has a unique mechanism of action that does not directly involve the secretion of insulin but promotes the excretion of glucose in the kidneys. It is formulated as a mixture with anhydrous lactose to enhance formulation stability and absorption.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

63 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Combined ingredients

Ingredients used together with this ingredient in combination products.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.